Literature DB >> 12716780

Stretching the mutant prevention concentration (MPC) beyond its limits.

Heather J Smith1, Kimberly A Nichol, Daryl J Hoban, George G Zhanel.   

Abstract

Mesh：

Year:  2003        PMID： 12716780     DOI： 10.1093/jac/dkg255

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  15 in total

Review 1.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance.

Authors:  C Andrew DeRyke; Su Young Lee; Joseph L Kuti; David P Nicolau
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogens.

Authors:  Elizabeth D Hermsen; Laurie B Hovde; George N Konstantinides; John C Rotschafer
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

4.  Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.

Authors:  Arnab Majhi; Rana Adhikary; Aritra Bhattacharyya; Sayantika Mahanti; Biswadev Bishayi
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

5.  Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.

Authors:  Anne-Sylvie Kesteman; Aude A Ferran; Agnès Perrin-Guyomard; Michel Laurentie; Pascal Sanders; Pierre-Louis Toutain; Alain Bousquet-Mélou
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

6.  Mutant prevention concentrations of four carbapenems against gram-negative rods.

Authors:  Kim Credito; Klaudia Kosowska-Shick; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

7.  Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance.

Authors:  Kathleen M Frey; Kishore Viswanathan; Dennis L Wright; Amy C Anderson
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

8.  Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  E Dahdouh; S H Shoucair; S E Salem; Z Daoud
Journal:  ScientificWorldJournal       Date:  2014-12-30

Review 9.  The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials.

Authors:  Alicia Rodríguez-Gascón; María Ángeles Solinís; Arantxa Isla
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

10.  In Vitro Antibiofilm Efficacies of Different Antibiotic Combinations with Zinc Sulfate against Pseudomonas aeruginosa Recovered from Hospitalized Patients with Urinary Tract Infection.

Authors:  Walid Elkhatib; Ayman Noreddin
Journal:  Antibiotics (Basel)       Date:  2014-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.